Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF).

This study investigates the efficacy and safety of febuxostat in chronic heart failure patients with hyperuricemia. PMID: 30101851 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30101851?dopt=Abstract

Source: International Heart Journal - August 15, 2018 Category: Cardiology Tags: Int Heart J Source Type: research